Literature DB >> 34999609

Diabetes mellitus is associated with declines in physical function among men with and without HIV.

Mary C Masters1, Jingyan Yang2, Jordan E Lake3, Alison G Abraham4,5, Lawrence Kingsley6,7, Todd T Brown8, Frank J Palella1, Kristine M Erlandson9.   

Abstract

OBJECTIVE: To determine the longitudinal relationships between abnormal glucose metabolism and physical function in persons with HIV (PWH) and without HIV.
DESIGN: Prospective cohort study of men with or at risk for HIV in four United States cities between 2006 and 2018.
METHODS: Men with or at risk for HIV from the Multicenter AIDS Cohort Study (MACS) had semi-annual assessments of glycemic status, grip strength, and gait speed. We used linear mixed models with random intercept to assess associations between glycemic status and physical function. Glycemic status was categorized as normal, impaired fasting glucose (IFG), controlled diabetes mellitus [hemoglobin A1C (HbA1C) <7.5%], or uncontrolled diabetes mellitus (HbA1C ≥ 7.5%).
RESULTS: Of 2240 men, 52% were PWH. Diabetes mellitus was similar among PWH (7.7%) vs. persons without HIV (6.7%, P = 0.36) at baseline. PWH had slower gait speed (1.17 vs. 1.20 m/s, P < 0.01) but similar grip strength (40.1 vs. 39.8 kg, P = 0.76) compared with persons without HIV at baseline. In multivariate models, gait speed decline was greater with controlled diabetes mellitus [-0.018 m/s (-0.032 to -0.005), P = 0.01] and grip strength decline was greater with controlled [-0.560 kg (-1.096 to -0.024), P = 0.04] and uncontrolled diabetes mellitus [-0.937 kg (-1.684 to -0.190), P = 0.01), regardless of HIV serostatus compared with normoglycemic individuals. DISCUSSION: Abnormal glucose metabolism was associated with declines in gait speed and grip strength regardless of HIV serostatus. These data suggest that improvement in glucose control should be investigated as an intervenable target to prevent progression of physical function limitations among PWH.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34999609      PMCID: PMC8957604          DOI: 10.1097/QAD.0000000000003160

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  81 in total

Review 1.  Metformin as a Tool to Target Aging.

Authors:  Nir Barzilai; Jill P Crandall; Stephen B Kritchevsky; Mark A Espeland
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

2.  Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.

Authors:  Kristine M Erlandson; Derek K Ng; Lisa P Jacobson; Joseph B Margolick; Adrian S Dobs; Frank J Palella; Jordan E Lake; Hanhvy Bui; Lawrence Kingsley; Todd T Brown
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

3.  Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome.

Authors:  Kathleen V Fitch; Ellen J Anderson; Jane L Hubbard; Sara J Carpenter; William R Waddell; Angela M Caliendo; Steven K Grinspoon
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

4.  Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants.

Authors:  Heliodoro Alemán-Mateo; Miriam T López Teros; Fátima A Ramírez; Humberto Astiazarán-García
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-12-10       Impact factor: 6.053

5.  Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.

Authors:  Todd T Brown; Katherine Tassiopoulos; Ronald J Bosch; Cecilia Shikuma; Grace A McComsey
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

6.  Accelerated atrophy of lower leg and foot muscles--a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI).

Authors:  C S Andreassen; J Jakobsen; S Ringgaard; N Ejskjaer; H Andersen
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

7.  Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes.

Authors:  Ryotaro Bouchi; Tatsuya Fukuda; Takato Takeuchi; Yujiro Nakano; Masanori Murakami; Isao Minami; Hajime Izumiyama; Koshi Hashimoto; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  Diabetes Metab Res Rev       Date:  2017-11-23       Impact factor: 4.876

8.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

9.  Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity.

Authors:  Takahiro Horiuchi; Natsumi Sakata; Yoshihiro Narumi; Tomohiro Kimura; Takashi Hayashi; Keisuke Nagano; Keyue Liu; Masahiro Nishibori; Sohei Tsukita; Tetsuya Yamada; Hideki Katagiri; Ryutaro Shirakawa; Hisanori Horiuchi
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

10.  Gait speed and body mass index: Results from the AMI study.

Authors:  Maturin Tabue-Teguo; Karine Perès; Nadine Simo; Mélanie Le Goff; Mario Ulises Perez Zepeda; Catherine Féart; Jean-François Dartigues; Hélène Amieva; Matteo Cesari
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.